前列腺癌PSMA PET阴囊摄取:结合超声鉴别转移灶与良性及生理性表现
回顾性纳入114例前列腺癌患者,评估PSMA PET阴囊摄取的强度、分布、偏侧性及SUVmax,并与100天内的阴囊超声对照。24例(21%)有阴囊摄取,其中5例确认转移,均表现为局灶、单侧、浓密摄取;17例轻度局灶摄取中16例(94%)超声无异常,符合生理性附睾摄取。LASSO回归显示摄取强度、SUVmax、PET指征和偏侧性为转移的显著预测因子,PET指征关联最强(系数=4.60)。
要点
- 阴囊局灶、单侧、浓密PSMA摄取,尤其在再分期时,与睾丸或睾丸旁转移强相关。
- 轻度或双侧摄取且超声无异常,通常为生理性,多无需进一步处理。
- 结合阴囊超声可提高PSMA PET阴囊摄取的诊断准确性。
核心结论
- 局灶、单侧、浓密PSMA摄取,尤其在再分期时,与睾丸或睾丸旁转移强相关;轻度或双侧摄取且超声无异常通常为生理性,联合PSMA PET与阴囊超声可提高诊断准确性。
研究设计与样本
- IRB批准的回顾性研究,纳入2021年7月至2025年5月间接受PSMA PET-CT或PET-MRI且100天内行阴囊超声的前列腺癌患者114例(平均年龄70岁),以病理或三位委员会认证放射科医师的临床共识确认转移。
诊断标准与关键数值
- 24例(21%)有阴囊PSMA摄取:6例局灶浓密摄取(均单侧),17例轻度局灶摄取(13例双侧、4例单侧),1例轻度弥漫双侧摄取,无浓密弥漫摄取;5例确认转移,均表现为局灶、单侧、浓密摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify imaging and clinical features that aid in distinguishing metastatic lesions from benign or physiologic uptake on PSMA PET, using correlation with scrotal ultrasound.
METHODS: This IRB-approved retrospective study included prostate cancer (PCa) patients who underwent PSMA PET-CT or PET-MRI between July 2021 and May 2025, with a scrotal ultrasound performed within 100 days of the scan. PSMA-avid lesions were assessed for uptake intensity (mild vs. intense), distribution (diffuse vs. focal), laterality (unilateral vs. bilateral), scan indication (initial staging vs. restaging), and SUVmax. Ultrasound findings were reviewed, and metastasis was confirmed by pathology or clinical consensus by three board-certified radiologists. Multivariable logistic regression using LASSO was performed to identify predictors of testicular or paratesticular metastasis.
RESULTS: Of 114 patients (mean age 70), 24 (21%) demonstrated scrotal PSMA uptake. Focal intense uptake was seen in 6 patients (all unilateral), and mild focal uptake in 17 (13 bilateral, 4 unilateral). One patient showed mild diffuse bilateral uptake; no cases had intense diffuse uptake. Metastasis was confirmed in 5 patients, all of whom showed focal, unilateral, intense uptake. Among the 17 with mild focal uptake, 16 (94%) had no ultrasound abnormalities, consistent with physiologic epididymal uptake. Of 12 patients with ultrasound findings of epididymitis or orchitis, only 2 showed PSMA uptake (1 intense, 1 mild), while 10 had none. LASSO regression identified uptake intensity, SUVmax, PET indication, and laterality as significant predictors of metastasis. PET indication showed the strongest association with metastasis (coefficient = 4.60), followed by uptake intensity (3.97), SUVmax (1.37), and laterality (0.37), indicating a higher likelihood of metastasis in unilateral, intensely avid lesions, particularly in restaging settings.
CONCLUSION: Focal, unilateral, intense PSMA uptake, especially during restaging, was strongly associated with testicular or paratesticular metastasis. In contrast, mild or bilateral uptake without ultrasound abnormalities was typically physiologic. Combined assessment using PSMA PET and scrotal ultrasound improves diagnostic accuracy in evaluating scrotal findings in PCa patients.
引用
- Takahashi H, Potretzke TA, Ehman EC, et al. Scrotal uptake on PSMA PET in prostate cancer: differentiating metastases from benign and physiologic findings using ultrasound correlation. Abdom Radiol (NY). 2026. PMID: 41801384. doi:10.1007/s00261-026-05408-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。